Opinion · 29 May 2025
Conference abstractPublished 2018
Access is more than price
Global Health Access Solutions, Poland
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Modern diagnostic and therapeutic procedures including advanced surgeries, organ transplants and immunotherapy, are pillared on antimicWith increased attention by governments and the public on prices for medicines, it is important to address these concerns. Often the price debate is overlooking the underlying issues at hand. When talking about increasing access to patients it is important steer away from current assumption and adopts market access strategies accordingly. Therefore, it is important to broaden the debate from market access towards access. The shift is not merely semantic but has practical implications. When looking at the access conundrum, price is often only one factor to consider. By far the most crucial factor is insurance and its widespread availability for patients. Only innovative insurance and payment schemes will help governments to control prices and enable companies to increase access for patients. The session will look at practical examples and outline solutions for a successful launch of new health solutions. These will ultimately benefit patients and society as whole.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 31 Mar 2025
Value-based Pricing: Optimizing Pharmaceutical Value and Access
Perspective · 10 Jan 2024
Evaluating the effectiveness of pharmaceutical price controls in enhancing access to essential medications.
Short communication · 19 May 2016
A critical study on availability and price variation between different brands: Impact on access to medicines
Editorial · 2016
Drug Price Control May Fail to Improve the Access for Patients and Exploitation of Research Innovation
More from this journal
The newest in Journal of Forensic Toxicology & Pharmacology.
Opinion · 26 Dec 2024
Legal Intoxication Levels: Insights from Forensic Toxicology
Commentary · 26 Dec 2024
Predictive Models for Toxicokinetics in Pharmaceuticals
Perspective · 26 Dec 2024
High-Performance Liquid Chromatography in Clinical Toxicology: Enhancing Diagnostic Precision
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Forensic Toxicology & Pharmacology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sebastian Gensior”

